Evidence map›Paper›PMID 30576349›Full record

ArticlePloS one2018

Reduced RNA expression of the FMR1 gene in women with low (CGGn<26) repeats.

Qi Wang, David H Barad, Sarah K Darmon, Vitaly A Kushnir, Yan-Guang Wu, Emanuela Lazzaroni-Tealdi, Lin Zhang, David F Albertini, Norbert Gleicher

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 18 citations in OpenAlex.

  1. Regulation of Bone Morphogenetic Protein Receptor Type II Expression byInternational journal of molecular sciences · 2024
    Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Qi WangThe Center for Human Reproduction, New York, NY, United States of America.
David H BaradThe Center for Human Reproduction, New York, NY, United States of America.ORCID 0000-0002-7980-2369
Sarah K DarmonThe Center for Human Reproduction, New York, NY, United States of America.
Vitaly A KushnirThe Center for Human Reproduction, New York, NY, United States of America.
Yan-Guang WuThe Center for Human Reproduction, New York, NY, United States of America.
Emanuela Lazzaroni-TealdiThe Center for Human Reproduction, New York, NY, United States of America.
Lin ZhangThe Center for Human Reproduction, New York, NY, United States of America.
David F AlbertiniThe Center for Human Reproduction, New York, NY, United States of America.
Norbert GleicherThe Center for Human Reproduction, New York, NY, United States of America.
Center for Human Reproduction · USFoundation for Reproductive Medicine · USThe University of Kansas Health System · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Low FMR1 variants (CGGn<26) have been associated with premature ovarian aging, female infertility and poor IVF treatment success. Until now, there is little published information concerning possible molecular mechanisms for this effect. We wished to examine whether relative expression of RNA and the FMR1 gene's fragile X mental retardation protein (FMRP) RNA isoforms differ in women with various FMR1 sub-genotypes (normal, low CGGn<26 and/or high CGGn≥34). This prospective cohort study was conducted between 2014 and 2017 in a clinical research unit of the Center for Human Reproduction in New York City. The study involved a total of 98 study subjects, including 18 young oocyte donors and 80 older infertility patients undergoing routine in vitro fertilization (IVF) cycles. The main outcome measure was RNA expression in human luteinized granulosa cells of 5 groups of FMRP isoforms. The relative expression of FMR1 RNA in human luteinized granulosa cells was measured by real-time PCR and a possible association with CGGn was explored. All 5 groups of FMRP RNA isoforms examined were found to be differentially expressed in human luteinized granulosa cells. The relative expression of four FMR1 RNA isoforms showed significant differences among 6 FMR1 sub-genotypes. Women with at least one low allele expressed significantly lower levels of all 5 sets of FRMP isoforms in comparison to the non-low group. While it would be of interest to see whether FMRP is also decreased in the low-group we recognize that in recent years it has been increasingly documented that information flow of genetics may be regulated by non-coding RNA, that is, without translation to a protein product. We, thus, conclude that various CGG expansions of FMR1 allele may lead to changes of RNA levels and ratios of distinct FMRP RNA isoforms, which could regulate the translation and/or cellular localization of FMRP, affect the expression of steroidogenic enzymes and hormonal receptors, or act in some other epigenetic process and therefore result in the ovarian dysfunction in infertility.

Indexed as

5' Untranslated RegionsAdultAllelesAmino Acid SequenceBase SequenceCohort StudiesFemaleFertilization in VitroFragile X Messenger Ribonucleoprotein 1Fragile X SyndromeGene ExpressionGranulosa CellsHumansInfertility, FemaleOvarian ReservePrimary Ovarian Insufficiency5' Untranslated RegionsFMR1 protein, humanFragile X Messenger Ribonucleoprotein 1Protein IsoformsRNA

Identifiers

PMID30576349
PMCPMC6303073
OpenAlexW2906017994

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.